Keith I Block

Summary

Affiliation: Block Center for Integrative Cancer Care
Country: USA

Publications

  1. ncbi Antioxidants and cancer therapy: furthering the debate
    Keith I Block
    Institute for Integrative Cancer Research and Education, Evanston, Illinois 60201, USA
    Integr Cancer Ther 3:342-8. 2004
  2. ncbi Breaking bad news
    Keith I Block
    Institute for Integrative Cancer Research and Education, 1800 Sherman Ave, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 2:39-62. 2003
  3. ncbi The challenges of randomized trials in integrative cancer care
    Keith I Block
    Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston IL 60201, USA
    Integr Cancer Ther 3:112-27. 2004
  4. ncbi Immune system effects of echinacea, ginseng, and astragalus: a review
    Keith I Block
    Institute for Integrative Cancer Care and Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 2:247-67. 2003
  5. ncbi Integrative tumor board: metastatic renal cell carcinoma: integrative physician's perspective
    Keith I Block
    Medical Director, Block Center for Integrative Cancer Care, 1800 Sherman Ave, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 3:44-6. 2004
  6. ncbi Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes
    Keith I Block
    Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 1:83-9. 2002
  7. ncbi Survival impact of integrative cancer care in advanced metastatic breast cancer
    Keith I Block
    Block Center for Integrative Cancer Treatment, Evanston, Illinois 60201, USA
    Breast J 15:357-66. 2009
  8. ncbi Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials
    Keith I Block
    Institute for Integrative Cancer Research and Education, Suite 350, Evanston, IL, USA
    Int J Cancer 123:1227-39. 2008
  9. ncbi Integrative tumor board: recently diagnosed lung cancer
    Michael De La Torre
    Block Center for Integrative Cancer Care, Evanston, IL 60201, USA
    Integr Cancer Ther 1:246-65. 2002
  10. ncbi Integrative tumor board: Esophageal cancer
    Michael De La Torre
    Block Center for Integrative Cancer Care, Evanston, IL 60201, USA
    Integr Cancer Ther 1:44-66. 2002

Collaborators

Detail Information

Publications61

  1. ncbi Antioxidants and cancer therapy: furthering the debate
    Keith I Block
    Institute for Integrative Cancer Research and Education, Evanston, Illinois 60201, USA
    Integr Cancer Ther 3:342-8. 2004
    ....
  2. ncbi Breaking bad news
    Keith I Block
    Institute for Integrative Cancer Research and Education, 1800 Sherman Ave, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 2:39-62. 2003
  3. ncbi The challenges of randomized trials in integrative cancer care
    Keith I Block
    Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston IL 60201, USA
    Integr Cancer Ther 3:112-27. 2004
  4. ncbi Immune system effects of echinacea, ginseng, and astragalus: a review
    Keith I Block
    Institute for Integrative Cancer Care and Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 2:247-67. 2003
    ..Although the margin of safety for these herbs is large, more research is needed to demonstrate the clear value of using herbs to improve resistance to infections...
  5. ncbi Integrative tumor board: metastatic renal cell carcinoma: integrative physician's perspective
    Keith I Block
    Medical Director, Block Center for Integrative Cancer Care, 1800 Sherman Ave, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 3:44-6. 2004
  6. ncbi Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes
    Keith I Block
    Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 1:83-9. 2002
    ....
  7. ncbi Survival impact of integrative cancer care in advanced metastatic breast cancer
    Keith I Block
    Block Center for Integrative Cancer Treatment, Evanston, Illinois 60201, USA
    Breast J 15:357-66. 2009
    ..Further research to evaluate the impact of integrative breast cancer treatment on survival is warranted...
  8. ncbi Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials
    Keith I Block
    Institute for Integrative Cancer Research and Education, Suite 350, Evanston, IL, USA
    Int J Cancer 123:1227-39. 2008
    ..However, well-designed studies evaluating larger populations of patients given specific antioxidants defined by dose and schedule relative to chemotherapy are warranted...
  9. ncbi Integrative tumor board: recently diagnosed lung cancer
    Michael De La Torre
    Block Center for Integrative Cancer Care, Evanston, IL 60201, USA
    Integr Cancer Ther 1:246-65. 2002
  10. ncbi Integrative tumor board: Esophageal cancer
    Michael De La Torre
    Block Center for Integrative Cancer Care, Evanston, IL 60201, USA
    Integr Cancer Ther 1:44-66. 2002
  11. ncbi Integrative tumor board: colon cancer with liver metastases: case presentation
    Jennifer R Schmaltz
    Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 2:166-198. 2003
  12. ncbi Mega-dose vitamin and mineral therapy in breast cancer: a clinician's perspective
    Keith I Block
    Block Center for Integrative Cancer Care, Evanston, Illinois; University of Illinois at Chicago College of Medicine, Chicago, Illinois
    Integr Cancer Ther 2:163-5. 2003
  13. ncbi Vitamin C in alternative cancer treatment: historical background
    Keith I Block
    Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 2:147-54. 2003
    ..Controversy about these trials still persists, however, in the alternative cancer community...
  14. ncbi Mega-dose vitamins and breast cancer
    Keith I Block
    Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 2:145-6. 2003
  15. ncbi Integrative tumor board: metastatic breast cancer
    Amanda Koch
    Block Center for Integrative Cancer Treatment, Evanston, IL 60201, USA
    Integr Cancer Ther 5:373-90. 2006
  16. ncbi Making circadian cancer therapy practical
    Keith I Block
    Block Center for Integrative Cancer Treatment, Evanston, IL 60201, USA
    Integr Cancer Ther 8:371-86. 2009
    ..Integrating all the above treatment modalities has the potential to improve both the quality of life and disease outcomes in cancer patients...
  17. ncbi Commentary: the pharmacological antioxidant amifostine -- implications of recent research for integrative cancer care
    Keith I Block
    Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 4:329-51. 2005
    ..The authors discuss the implications of this research for patient populations seen in integrative cancer care centers and for research on phytochemical antioxidants such as vitamins and carotenoids...
  18. ncbi Point-counterpoint: using clinical trials for the evaluation of integrative cancer therapies
    Keith I Block
    Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 3:66-81. 2004
  19. ncbi Integrative tumor board: Recurrent lymphoma
    April Yuning Feng
    Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 3:238-56. 2004
  20. ncbi Integrative tumor board: transitional cell carcinoma of the bladder
    April Yuning Feng
    Block Center for Integrative Cancer Care, 1800 Sherman Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 4:48-64. 2005
  21. ncbi Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials
    Keith I Block
    Institute for Integrative Cancer Research and Education, 1800 Sherman Avenue, Suite 350, Evanston, IL 60201, USA
    Cancer Treat Rev 33:407-18. 2007
    ..The objective of this study is to systematically review the literature in order to compile results from randomized trials that evaluate concurrent use of antioxidants with chemotherapy...
  22. ncbi The demise of the super-aspirins: an opportunity for integrative medicine?
    Keith I Block
    Block Center for Integrative, Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 4:5-7. 2005
    ..Clinical studies for evaluating these interventions, and research on sustainable production of those that are natural substances, should be given greater funding priority at this time...
  23. ncbi Integrative tumor board: Advanced breast cancer
    Victoria Kut
    Block Center for Integrative Cancer Care, Evanston, IL 60201, USA
    Integr Cancer Ther 1:179-214. 2002
  24. ncbi Integrative tumor board: recurrent breast cancer or new primary? Integrative physician's perspective
    Keith I Block
    Block Center for Integrative Cancer Care, 1800 Sherman Ave, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 2:301-5. 2003
  25. ncbi The role of optimal healing environments in patients undergoing cancer treatment: clinical research protocol guidelines
    Keith I Block
    Block Medical Center, Evanston, IL 60201, USA
    J Altern Complement Med 10:S157-70. 2004
    ..Based on the authors' clinical experience, an OHE for patients with cancer is described and suggestions for meaningful research are identified...
  26. ncbi Safety and efficacy of herbal sedatives in cancer care
    Keith I Block
    Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 3:128-48. 2004
    ....
  27. ncbi Toward a core nutraceutical program for cancer management
    Mark F McCarty
    Block Center for Integrative Cancer Care, Evanston, IL 60201, USA
    Integr Cancer Ther 5:150-71. 2006
    ..It would be of interest to test this program in nude mouse xenograft models...
  28. ncbi Point-counterpoint: soy intake for breast cancer patients
    Keith I Block
    Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 1:90-100. 2002
  29. ncbi Point-counterpoint: the immune system in cancer
    Keith I Block
    Block Center for Integrative Cancer Care, Evanston, IL 60201, USA
    Integr Cancer Ther 1:294-316. 2002
  30. ncbi Multifocal angiostatic therapy: an update
    Mark F McCarty
    Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 4:301-14. 2005
    ..The potential complementary of the components of MAT should be assessed in nude mouse xenograft models...
  31. ncbi Preadministration of high-dose salicylates, suppressors of NF-kappaB activation, may increase the chemosensitivity of many cancers: an example of proapoptotic signal modulation therapy
    Mark F McCarty
    Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 5:252-68. 2006
    ..These strategies may also have potential as adjuvants to metronomic chemotherapy, which seeks to suppress angio-genesis by targeting cycling endothelial cells in tumors...
  32. ncbi Chronomodulated chemotherapy: clinical value and possibilities for dissemination in the United States
    Keith I Block
    Institute for Integrative Cancer Care and Block Medical Center, Evanston, Illinois, USA
    Chronobiol Int 19:275-87. 2002
    ..Under the current method of insurance reimbursement, the advancement of chronotherapy in the United States is threatened despite evidence that such treatment is both therapeutically sound and cost-effective...
  33. ncbi Cancer, the mind, and the problem of self-blame
    Keith I Block
    Integrative Cancer Care, Evanston, IL 60201, USA
    Integr Cancer Ther 5:122-30. 2006
  34. ncbi Integrative tumor board: glioblastoma multiforme
    Sachin Dixit
    Block Center for Integrative Cancer Care, 1800 Sherman Ave, Evanston, IL 60201, USA
    Integr Cancer Ther 3:149-72. 2004
  35. ncbi Integrative tumor board: recurrence of ovarian cancer
    John V Knaus
    St. Francis Hospital, Evanston, IL 60202, USA
    Integr Cancer Ther 1:392-416. 2002
  36. ncbi Integrative Tumor Board: cholangicocarcinoma
    April Yuning Feng
    Integr Cancer Ther 5:131-49. 2006
  37. ncbi Pain, depression, and fatigue in cancer
    Keith I Block
    Integr Cancer Ther 1:323-6. 2002
  38. ncbi Integrative tumor board: recently diagnosed prostate cancer
    Mark J Schacht
    Integr Cancer Ther 2:63-90. 2003
  39. ncbi A step in the right direction
    Keith I Block
    Integr Cancer Ther 6:205-7. 2007
  40. ncbi On models for integrative medical practice
    Keith I Block
    Integr Cancer Ther 6:309-12. 2007
  41. ncbi Cancer's impact on social roles
    Keith I Block
    Integr Cancer Ther 7:3-4. 2008
  42. ncbi Pancreatic cancer
    Charlotte Gyllenhaal
    Integr Cancer Ther 7:103-13. 2008
  43. ncbi Why integrative therapies?
    Keith I Block
    Integr Cancer Ther 5:3-6. 2006
  44. ncbi Multiple molecular targets in oncology and integrative care
    Keith I Block
    Integr Cancer Ther 2:209-11. 2003
  45. ncbi Antioxidants in the news
    Keith I Block
    Integr Cancer Ther 4:271-3. 2005
  46. ncbi Panax ginseng: a role in cancer therapy?
    Yuan S Chang
    School of Pharmacy, China Medical College, Taichung, Taiwan, Republic of China
    Integr Cancer Ther 2:13-33. 2003
    ..Cancer patients may empirically find ginseng to be useful when they are fatigued, although clinical trials should be conducted to confirm its benefits...
  47. ncbi Integrative cancer care and the art of medicine
    Keith I Block
    Integr Cancer Ther 2:3-4. 2003
  48. ncbi Timing is everything
    Keith I Block
    Integr Cancer Ther 2:103-4. 2003
  49. ncbi Editorial: just in cases
    Keith I Block
    Integr Cancer Ther 6:5-7. 2007
  50. ncbi An antioxidant turnabout
    Keith I Block
    Integr Cancer Ther 7:59-61. 2008
  51. ncbi Cardiac glycosides as novel cancer therapeutic agents
    Robert A Newman
    Department of Experimental Therapeutics and Pharmaceutical Development Center, University of Texas, M D Anderson Cancer Center, Houston, TX 77054, USA
    Mol Interv 8:36-49. 2008
    ..This review focuses on recent findings on cellular pharmacology of cardiac glycosides as they relate to treatment of human cancer and attempts to explain why these agents have been overlooked in the past...
  52. ncbi "Top of the hierarchy" evidence for integrative medicine: what are the best strategies?
    Keith I Block
    Integr Cancer Ther 5:277-81. 2006
  53. ncbi Recapturing the Patient's Voice
    Keith I Block
    Integr Cancer Ther 4:107-9. 2005
  54. ncbi Challenges of complementary and alternative medicine research
    Keith I Block
    Integr Cancer Ther 4:207-9. 2005
  55. ncbi Antineoplastons and the challenges of research in integrative care
    Keith I Block
    Integr Cancer Ther 3:3-4. 2004
  56. ncbi A tale of 2 studies: diet and breast cancer
    Keith I Block
    Integr Cancer Ther 5:95-7. 2006
  57. ncbi Editorial: On psycho-oncology, lycopene and the Noni fruit
    Keith I Block
    Integr Cancer Ther 1:107-9. 2002
  58. ncbi Editorial: Looking beyond the obvious
    Keith I Block
    Integr Cancer Ther 1:227-8. 2002
  59. ncbi Editorial: Integrative cancer treatment in the 21st century
    Keith I Block
    Integr Cancer Ther 1:3-6. 2002
  60. ncbi Inflammation, COX-2 inhibitors, and cancer
    Keith I Block
    Integr Cancer Ther 4:3-4. 2005
  61. ncbi Optimal healing environments and integrative cancer therapy
    Keith I Block
    Integr Cancer Ther 3:95-7. 2004